Group 1 - The core viewpoint of the news is that Baiyang Pharmaceutical's stock has experienced fluctuations, with a recent decline of 2.04% and a total market value of 12.883 billion yuan [1] - As of January 12, Baiyang Pharmaceutical's stock price is 24.51 yuan per share, with a trading volume of 27.9698 million yuan and a turnover rate of 0.22% [1] - The company has seen a year-to-date stock price increase of 3.86%, but a decline of 2.85% over the last five trading days [1] Group 2 - Baiyang Pharmaceutical reported a revenue of 5.627 billion yuan for the period from January to September 2025, representing a year-on-year decrease of 8.41% [2] - The net profit attributable to the parent company for the same period was 476 million yuan, down 25.67% year-on-year [2] - The company has distributed a total of 1.551 billion yuan in dividends since its A-share listing, with 1.201 billion yuan distributed in the last three years [3] Group 3 - As of September 30, 2025, the number of shareholders in Baiyang Pharmaceutical decreased by 40.83% to 11,100 [2] - The average number of circulating shares per person increased by 68.99% to 47,194 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is a new entrant, holding 2.9097 million shares [3]
百洋医药跌2.04%，成交额2796.98万元，主力资金净流出251.59万元